SCHEMBL31529366

SCHEMBL31529366

COc1cc2ccccc2nc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.61
PDE10A Q9Y233 1/20 0.61
TLR8 Q9NR97 1/20 0.59
ALDH1A1 P00352 6/20 0.58
KDM4E B2RXH2 5/20 0.58
LMNA P02545 4/20 0.58
GAA P10253 2/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
HPGD P15428 2/20 0.56
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
MAPK1 P28482 1/20 0.54
RECQL P46063 1/20 0.54
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
WHR1 P49842 1/20 0.50
POLB P06746 1/20 0.49
GLA P06280 1/20 0.49
MAPT P10636 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10641295 1.00 L3MBTL1 (0.61) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL9847504 0.95 L3MBTL1 (0.60) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL9590284 0.89 TLR8 (0.67) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL12970331 0.87 POLB (0.55) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL29366598 0.85 PDE10A (0.59) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL4260071 0.84 PDGFRB (0.55) L3MBTL1PDE10ATLR8ALDH1A1GAA
SCHEMBL29207074 0.84 KDM4E (0.62) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL30486859 0.84 L3MBTL1 (0.59) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL29207032 0.84 L3MBTL1 (0.59) L3MBTL1PDE10ATLR8ALDH1A1KDM4E
SCHEMBL12970102 0.83 TLR8 (0.49) L3MBTL1PDE10ATLR8ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145599-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MRJA THERAPEUTICS, INC. 2025-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145599-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS IGF1R, IGFBP1, IGFBP2 L3MBTL1 4482/4885PDE10A 828/4885TLR8 4322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.